Effects of Spironolactone on the Tubulointerstitium in Progressive Diabetic Kidney Disease

FEI Pei,JIA Ruhan,TU Yafang,DING Guohua
2009-01-01
Abstract:Objective: To investigate the effects of spironolactone on the tubulointerstitium damage in experimental type 1 diabetic rats.Methods: The SD rats were divided into three groups as follows: normal group,diabetic group,and spironolactone treatment group.Diabetes was induced by intraperitoneal injection of streptozotocin.Eight weeks later,blood pressure was measured in all animals,samples were collected to determine urinary protein excreted in 24 hours,serum creatinine(Scr),serum potassium,blood glucose,and endogenous creatinine clearance rate.Renal tissue morphology was observed by light microscope.Mineralocorticoid receptor(MR),matrix metalloproteinase-2(MMP-2),and alpha smooth muscle actin(α-SMA) in renal tubular epithelial cells were detected by immunohistochemistry of SP method.Computer image-pattern analysis system was used to analyze the expression of MR,MMP-2,and α-SMA in renal tubulointerstitium.Results: Rats proximal tubular cells expressed MR,and the expression of MR in proximal tubular cells in diabetic rats was higher than in the controls(P<0.01),but the elevated MR levels were not reduced after the treatment of spironolactone.The expression of MMP-2 and α-SMA in tubulointerstitium in diabetic rats was higher than in the controls respectively(both P<0.01).After spironolactone treatment,the expression of MMP-2 as well as α-SMA were markedly decreased compared with that in diabetic group respectively(both P<0.01),renal function and tubulointerstitium lesions was ameliorated.Spironolactone did not influence blood pressure and serum potassium(P>0.05),and the expression of α-SMA was positively correlated with the expression of MMP-2(r=0.920,P<0.01).Conclusion: Rats proximal tubular cells express MR,and the increase of the levels of MR is involved in the mechanism of diabetese-induced renal fibrosis.Spironolactone can prevent tubulointerstitium damage in progressive diabetic kidney disease.The mechanism may be associated,at least in part,with inhibiting renal tubular epithelial myofibroblast transdifferentiation,and down-regulating the MMP-2 and α-SMA expression in tubulointerstitium.
What problem does this paper attempt to address?